Alkermes (ALKS)
(Real Time Quote from BATS)
$28.43 USD
+0.56 (2.01%)
Updated Sep 18, 2025 12:54 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Alkermes plc has a market cap of $4.60B, which represents its share price of $27.87 multiplied by its outstanding shares number of 165.08M. As a mid-cap company, ALKS's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ALKS 28.43 +0.56(2.01%)
Will ALKS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ALKS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALKS
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue?
Krystal Biotech (KRYS) Up 8.5% Since Last Earnings Report: Can It Continue?
ALKS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales
Alkermes (ALKS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Other News for ALKS
ALKS forms 50 Day Moving Average Resistance on September 17
Is ALKS building bearish momentum? Lower Bollinger Band Walk shows up after advancing 3.28%
IYH: Healthcare Dashboard For September
ALKS forms NR7 on September 15
Tracking Baker Brothers Portfolio - Q2 2025 Update